Skip to main content

Table 2 Outcome of Kaposi sarcoma patients with IRIS and non-IRIS; treated with chemotherapy or without it, at time of last follow-up

From: Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma

  IRIS-KS (N = 35) Non-IRIS-KS (N = 54) Total (N = 89)
CR PR Death CR PR Death CR PR Death
Chemotherapy—N (%) 19 (54) 3 (9)a 9 (26) 15 (28) 0 2 (4) 34 (38) 3 (3) 11 (12)
No-chemotherapy N (%) 4 (11) 0 0 33 (61) 1 (2) 3 (5) 37 (42) 1 (1) 3 (3)
Total, N (%) 23 (65) 3 (9) 9 (26) 48 (89) 1 (2) 5 (9) 71 (80) 4 (4) 14 (16)
  1. IRIS-KS immune reconstitution inflammatory syndrome-Kaposi’s sarcoma, CR complete response, PR partial response
  2. aOne patient abandoned treatment, had Kaposi’s sarcoma progression and died with AIDS and related comorbidities
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us